Our results clarify that MDK promotes cancer cell proliferation by suppressing the LKB1-AMPK axis, and MDK expression correlates with clinical outcomes and inversely correlates with LKB1/AMPK signaling pathway activation. The gene discussed is PRKAA1; the disease is cancer.